Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer

Biologicals

Volumn 34, Issue 2, 2006, Pages 109-112

  Asturias, Edwin J ^a,b   Grazioso, Carlos F ^c   Luna Fineman, Sandra ^d,e   Torres, Olga ^f   Halsey, Neal A ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Center for Health Studies   (Guatemala)

^c Hospital General San Juan de Dios   (Guatemala)

^d National Pediatric Oncology Unit   (Guatemala)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f Institute of Nutrition of Central America and Panama Guatemala   (Guatemala)

Author keywords

B cell immunity; Cancer chemotherapy; HIV infection; Immunodeficiency; Poliovirus excretion; Poliovirus infection

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER; CHILD; CONTROLLED STUDY; DEVELOPING COUNTRY; FECES ANALYSIS; FEMALE; GUATEMALA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS EXCRETION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FECES; GUATEMALA; HIV INFECTIONS; HUMANS; NEOPLASMS; POLIOVIRUS; VIRUS SHEDDING;

POLIOVIRUS;

EID: 33646772538     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2006.03.002     Document Type: Article

References (17)

1. MacLennan C., Dunn G., Huissoon A.P., Kumararatne D.S., Martin J., O'Leary P., et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363 (2004) 1509-1513
2. Triki H., Barbouche M.R., Bahri O., Bejaoui M., and Dellagi K. Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol 41 (2003) 1203-1211
3. Halsey N.A., Pinto J., Espinosa-Rosales F., Faure-Fontenla M.A., da Silva E., Khan A.J., et al. Search for poliovirus carriers among people with primary immune deficiency disease in the United Status, Mexico, Brazil, and the United Kingdom. Bull World Health Organ 82 (2004) 3-8
4. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., and Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 (2005) 587-635
5. Liste M.B., Natera I., Suarez J.A., Pujol F.H., Liprandi F., and Ludert J.E. Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children. J Clin Microbiol 38 (2000) 2873-2877
6. Permar S.R., Moss W.J., Ryon J.J., Monze M., Cutts F., Quinn T.C., et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis 183 (2001) 532-538
7. Moss W.J., Clements C.J., and Halsey N.A. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 81 (2003) 61-70
8. Mustafa M.M., Buchanan G.R., Winick N.J., McCracken G.H., Tkaczewski I., Lipscomb M., et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 20 (1998) 451-457
9. Nilsson A., De Milito A., Engström P., Nordin M., Narita M., Grillner L., et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 109 (2002) 1-6
10. Borkowsky W., Rigaud M., Krasinski K., Moore T., Lawrence R., and Pollack H. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J Pediatr 120 (1992) 371-375
11. Birx D.L., Rhoads J.L., Wright J.C., Burke D.S., and Redfield R.R. Immunologic parameters in early-stage HIV-seropositive subjects associated with vaccine responsiveness. J Acquir Immune Defic Syndr 4 (1991) 188-196
12. Chen R.T., Hausinger S., Dajani A.S., Hanfling M., Baughman A.L., Pallansch M.A., et al. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA 275 (1996) 1639-1645
13. Kroon F.P., van Dissel J.T., Labadie J., van Loon A.M., and van Furth R. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis 21 (1995) 1197-1203
14. Ryder R.W., Oxtoby M.J., Mvula M., Baende E., Nsa W., Davachi F., et al. Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 122 (1993) 697-702
15. Roberts L. Polio: the final assault?. Science 303 (2004) 1960-1968
16. Gouandjika-Vasilache I., Akoua-Koffi C., Begaud E., and Dosseh A. No evidence of prolonged enterovirus excretion in HIV-seropositive patients. Trop Med Int Health 10 (2005) 743-747
17. Hennessey K.A., Lago H., Diomande F., Akoua-koffi C., Caceres V.M., Pallansch M.A., et al. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire. J Infect Dis 192 (2005) 2124-2128